Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion type Assertion NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_head.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion description "[The biological significance of these findings was established by showing that overexpression of two LMW cyclin E forms named cyclin E truncated 1 [cyclinE(T1)] and cyclin E truncated 2 [cyclinE(T2)] in a low tumorigenic and non-metastatic primary cutaneous melanoma cell line generated angiogenic tumors with prominent perineural invasion compared with full-length cyclin E. In addition, cyclin E(T1)- and cyclin E(T2)-expressing melanoma cells displayed a dramatic increase in the incidence and number of metastases in an experimental lung metastasis assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_provenance.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion evidence source_evidence_literature NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_provenance.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion SIO_000772 15705861 NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_provenance.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion wasDerivedFrom befree-20140225 NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_provenance.
- NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_assertion wasGeneratedBy ECO_0000203 NP582605.RAVjGrIVt-AW3zUlTYAOIkF6jHqlHByp8mRIwzFQt1bvg130_provenance.